136 related articles for article (PubMed ID: 32827448)
1. Identification and characterization of a novel isoform of heparin cofactor II in human liver.
Bano S; Fatima S; Ahamad S; Ansari S; Gupta D; Tabish M; Rehman SU; Jairajpuri MA
IUBMB Life; 2020 Oct; 72(10):2180-2193. PubMed ID: 32827448
[TBL] [Abstract][Full Text] [Related]
2. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
Boyle AJ; Roddick LA; Bhakta V; Lambourne MD; Junop MS; Liaw PC; Weitz JI; Sheffield WP
BMC Biochem; 2013 Mar; 14():6. PubMed ID: 23496873
[TBL] [Abstract][Full Text] [Related]
3. Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure.
Zhang GS; Mehringer JH; Van Deerlin VM; Kozak CA; Tollefsen DM
Biochemistry; 1994 Mar; 33(12):3632-42. PubMed ID: 7908224
[TBL] [Abstract][Full Text] [Related]
4. Role of the proposed serpin-enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes.
Maekawa H; Tollefsen DM
J Biol Chem; 1996 Aug; 271(31):18604-9. PubMed ID: 8702511
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants and evolutionary analyses of heparin cofactor II.
Kumar A; Bhandari A; Sarde SJ; Goswami C
Immunobiology; 2014 Sep; 219(9):713-28. PubMed ID: 24950623
[TBL] [Abstract][Full Text] [Related]
6. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.
Sarilla S; Habib SY; Tollefsen DM; Friedman DB; Arnett DR; Verhamme IM
Anal Biochem; 2010 Nov; 406(2):166-75. PubMed ID: 20670608
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of activation of heparin cofactor II by calcium spirulan.
Hayakawa Y; Hirashima Y; Yamamoto H; Kurimoto M; Hayashi T; Lee JB; Endo S
Arch Biochem Biophys; 2003 Aug; 416(1):47-52. PubMed ID: 12859981
[TBL] [Abstract][Full Text] [Related]
9. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
10. Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
Sarilla S; Habib SY; Kravtsov DV; Matafonov A; Gailani D; Verhamme IM
J Biol Chem; 2010 Mar; 285(11):8278-89. PubMed ID: 20053992
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
Kondo S; Tokunaga F; Kario K; Matsuo T; Koide T
Blood; 1996 Feb; 87(3):1006-12. PubMed ID: 8562924
[TBL] [Abstract][Full Text] [Related]
12. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues.
Kamp P; Strathmann A; Ragg H
Thromb Res; 2001 Mar; 101(6):483-91. PubMed ID: 11323006
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel alternatively spliced isoform of antithrombin containing an additional RCL-like loop.
Rehman SU; Ashraf S; Ahamad S; Sarwar T; Husain MA; Ahmad P; Tabish M; Jairajpuri MA
Biochem Biophys Res Commun; 2019 Sep; 517(3):421-426. PubMed ID: 31378371
[TBL] [Abstract][Full Text] [Related]
14. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition.
Ciaccia AV; Monroe DM; Church FC
J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031
[TBL] [Abstract][Full Text] [Related]
15. Isolation of frog and chicken cDNAs encoding heparin cofactor II.
Colwell NS; Tollefsen DM
Thromb Haemost; 1998 Nov; 80(5):784-90. PubMed ID: 9843172
[TBL] [Abstract][Full Text] [Related]
16. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
Sutherland JS; Bhakta V; Filion ML; Sheffield WP
Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
18. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
19. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
Tollefsen DM
Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
[TBL] [Abstract][Full Text] [Related]
20. The interaction of glycosaminoglycans with heparin cofactor II.
Tollefsen DM
Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
